Journal
ADVANCED HEALTHCARE MATERIALS
Volume 5, Issue 18, Pages 2339-2344Publisher
WILEY
DOI: 10.1002/adhm.201600588
Keywords
-
Funding
- Ariane de Rothschild Foundation
Ask authors/readers for more resources
Chemical sensors based on programmable molecularly modified gold nanoparticles are tailored for the detection and discrimination between the breathprint of irritable bowel syndrome (IBS) and inflammatory bowel diseases (IBD). The sensors are examined in both lab-and real-world clinical conditions. The results reveal a discriminative power accuracy of 81% between IBD and IBS and 75% between Crohn's and Colitis states.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available